Adenoma Detection Rate Benchmarks: An Updated Analysis.

Area of Science:

• Gastroenterology
• Colorectal Cancer Screening
• Endoscopic Quality Metrics

Background:

• Early-onset colorectal cancer has led to a reduced screening age from 50 to 45 years.
• The American Society for Gastrointestinal Endoscopy recommends quality indicators for colonoscopy.
• Adenoma detection rate (ADR) is a key quality measure, with benchmarks established for patients aged 50+.

Purpose of the Study:

• To evaluate the impact of the new screening age on adenoma detection rate benchmarks.
• To determine if current benchmarks are applicable to the 45-50 age group.
• To explore potential gender-based differences in adenoma detection rates.

Main Methods:

• A review of five studies examining adenoma detection rates.
• Analysis of data including patients aged 45-50.
• Comparison of combined and gender-specific adenoma detection rates.

Main Results:

• Patients aged 45-50 should be included in ADR calculations using existing benchmarks (25% combined, or 20% female/30% male separately).
• Males consistently showed higher adenoma prevalence than females in studies separating genders.
• One study suggested separate gender-based benchmarks may be warranted.

Conclusions:

• Current adenoma detection rate benchmarks are adaptable for the 45-50 age group.
• Gender-specific adenoma detection rates might improve quality assessment in some practices.
• Further research is necessary to refine screening quality metrics for evolving colorectal cancer screening guidelines.